Molecular biologist and RNA therapeutics expert with experience in mRNA and circular RNA platform development across academia, biotech, and pharma. At Stanford, Michelle supports the RNA medicine program in developing next-generation RNA technologies. Previously, Michelle lead cross-functional teams at Sanofi and Nutcracker Therapeutics to advance mRNA cancer and infectious disease vaccines. She earned her Ph.D. in Molecular Microbiology from Tufts University, where she studied mechanisms of pathogenesis in tuberculosis.